Horse Chestnut, Citrullus Colocynthis Fruit Pulp, Black Cohosh, Sodium Chloride, Strychnos Nux-vomica Seed, Phytolacca Americana Root, And Strontium Carbonate
Generic Name: horse chestnut, citrullus colocynthis fruit pulp, black cohosh, sodium chloride, strychnos nux-vomica seed, phytolacca americana root, and strontium carbonate
Brand Names:
D-50
Pain in the sacral region.
Overview
Pain in the sacral region.
Uses
INDICATIONS Pain in the sacral region.
Dosage
SUGGESTED DOSAGE One dropper under tongue two times daily. Acute symptoms ½ dropper under tongue every 30 minutes for two hours.
Warnings
Warnings Use only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Storage
SHAKE WELL
Frequently Asked Questions
What is Horse Chestnut, Citrullus Colocynthis Fruit Pulp, Black Cohosh, Sodium Chloride, Strychnos Nux-vomica Seed, Phytolacca Americana Root, And Strontium Carbonate used for?▼
INDICATIONS Pain in the sacral region.
Can I take Horse Chestnut, Citrullus Colocynthis Fruit Pulp, Black Cohosh, Sodium Chloride, Strychnos Nux-vomica Seed, Phytolacca Americana Root, And Strontium Carbonate during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Horse Chestnut, Citrullus Colocynthis Fruit Pulp, Black Cohosh, Sodium Chloride, Strychnos Nux-vomica Seed, Phytolacca Americana Root, And Strontium Carbonate?▼
Warnings Use only if cap seal is unbroken. If pregnant or breastfeeding, ask a healthcare professional before use. Keep this and all medication out of the reach of children.
Related Medications
Mouse Epithelia
mouse epithelia
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: MUS MUSCULUS SKIN (.1 g/mL). Category: BLA.
Fission Molybdenum-99
fission molybdenum-99
Dosage form: LIQUID. Active ingredients: MOLYBDENUM MO-99 (200 mg/20mL). Category: DRUG FOR FURTHER PROCESSING.
Infliximab
infliximab
Tumor Necrosis Factor Blocker [EPC]
11 DESCRIPTION Infliximab, a tumor necrosis factor (TNF) blocker, is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions). It has a molecular weight of approximately 149.1 kilodaltons. Infliximab is produced by a recombinant murine myeloma cell line, SP2/0. Infliximab for injection is supplied as a sterile, preservative-free, white, lyophilized powder for intravenous infusion after reconstitution and dilution.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.